ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Women’s health"

  • Abstract Number: 1782 • ACR Convergence 2020

    Use of a Patient-reported Survey to Document Contraceptive Use and Interest in Pregnancy to Identify Patients with Unmet Pregnancy Prevention and Planning Needs

    Megan Clowse1, Amanda Eudy2, Lisa Criscione-Schreiber3, Jayanth Doss2, Kai Sun2, Rebecca Sadun2 and Jennifer Rogers4, 1Duke University, Chapel Hill, NC, 2Duke University, Durham, NC, 3Duke University School of Medicine, Durham, NC, 4Duke, Durham, NC

    Background/Purpose: Pregnancies in women with lupus who conceive when their disease is active or they are taking a teratogen are at increased risk for pregnancy…
  • Abstract Number: 0081 • ACR Convergence 2020

    Prevalence of Systemic Autoimmune Diseases in Polycystic Ovary Syndrome

    Saika Sharmeen1, Hafsa Nomani2, Erin Taub3 and Qingping Yao3, 1Stony Brook University Renaissance School of Medicine, Dix Hills, NY, 2Stony Brook University Renaissance School of Medicine, West Babylon, NY, 3Stony Brook University Renaissance School of Medicine, Stony Brook, NY

    Background/Purpose: Polycystic ovary syndrome (PCOS) is characterized by hormonal abnormality, chronic anovulation, hyperandrogenism, and obesity. Due to the hormonal imbalance, we hypothesize that patients with…
  • Abstract Number: 1838 • ACR Convergence 2020

    Aerobic Exercise Improves Fatigue and Quality of Life in Women with Systemic Lupus Erythematosus (Preliminary Analysis)

    Marquis Chapman1, Sarthak Gupta1, Jun Chu1, Mohammad Naqi1, Zerai Manna2, Mir Ali Mazhar1, Adam Munday1, Marybeth Stockman1, Anam Ahmad1, Gayle McCrossin1, Bart Drinkard1, Lisa Chin1, Mariana Kaplan3, Randall Keyser1, Leighton Chan1 and Sarfaraz Hasni2, 1National Institutes of Health, Bethesda, MD, 2Lupus Clinical Trials Unit, NIAMS/NIH, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease of female predominance. One of the most debilitating symptoms experienced by SLE-patients is persistent…
  • Abstract Number: 0274 • ACR Convergence 2020

    The Rising Incidence of Lupus Nephritis: A Population-Based Study of Four Decades

    Mehmet Hocaoglu1, Shirley-Ann Osei-Onomah2, Jesse Dabit3, Rachel Giblon3, Thomas O'Byrne3, Fernando C. Fervenza3, Cynthia Crowson4 and Ali Duarte-Garcia3, 1University of Maryland Medical Center Midtown Campus, Baltimore, MD, 2Mayo Clinic, Rochester, 3Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: Estimating the incidence of lupus nephritis (LN) is important to understand disease burden, particularly since patients with LN have a higher morbidity and mortality…
  • Abstract Number: 0278 • ACR Convergence 2020

    Trends in Incidence of Cutaneous Lupus Erythematosus from 1976 to 2018: A Population-Based Study

    Mehmet Hocaoglu1, Mark Denis P. Davis2, Shirley-Ann Osei-Onomah3, Jesse Dabit2, Rachel Giblon2, Thomas O'Byrne2, Cynthia Crowson4 and Ali Duarte-Garcia2, 1University of Maryland Medical Center Midtown Campus, Baltimore, MD, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Rochester, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: Cutaneous lupus erythematosus (CLE) is a heterogeneous chronic disease with potential for long lasting morbidity. Studies that provide incidence data on the entire spectrum…
  • Abstract Number: 0421 • ACR Convergence 2020

    Polymyalgia Rheumatica Is Associated with Later Menopause: An Observational Study

    Sarah Dyball1, Christopher Saleh2 and Marwan Bukhari1, 1Rheumatology Department, University Hospitals of Morecambe Bay NHS Trust, Lancaster, United Kingdom, 2Rheumatology Department, University Hospitals of Morecambe Bay NHS Trust, Manchester, United Kingdom

    Background/Purpose: Oestrogen exposure leads to an increase in peak bone mass whereas menopause is associated with rapid bone loss. Numerous studies have linked rheumatoid arthritis…
  • Abstract Number: 0437 • ACR Convergence 2020

    Integrating Reproductive Health in Systemic Lupus Erythematosus in a Tertiary Care Setting

    Jun Chu1, Sarthak Gupta1, Zerai Manna2, Michael Davis1, Yenealem Temesgen-Oyelakin1, Elaine Poncio1, Isabel Ochoa1, Laura Lewandowski3, Mariana Kaplan4, Alan Decherney1 and Sarfaraz Hasni2, 1National Institutes of Health, Bethesda, MD, 2Lupus Clinical Trials Unit, NIAMS/NIH, Bethesda, MD, 3NIAMS, NIH, Rockville, MD, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD

    Background/Purpose: Systemic Lupus Erythematosus (SLE) predominantly affects women of childbearing age. Women affected by SLE have higher risk for infertility, miscarriages, and other pregnancy complications…
  • Abstract Number: 2280 • 2019 ACR/ARP Annual Meeting

    Reproductive Health Intention Screening in Women with Systemic Rheumatic Diseases: Low Uptake and Gender-Specific Provider Patterns Following a Standardized Intervention

    Katherine Pryor1, Bill Albert 2, Susan Ritter 3, Laura Tarter 3, Jonathan Coblyn 3, Bonnie Bermas 4, Caryn Dutton 3, Lydia Pace 3, Elizabeth Janiak 3 and Candace Feldman 5, 1Brigham and Women's Hospital, Brookline, 2Power to Decide, Washington, DC, 3Brigham and Women's Hospital, Boston, 4UT Southwestern, Dallas, 5Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Reproductive health intention screening is critical in women with systemic rheumatic diseases, as both disease activity and medication use can impact pregnancy outcomes. However,…
  • Abstract Number: 2289 • 2019 ACR/ARP Annual Meeting

    Progesterone Decreases Gut Permeability Through Upregulating Occludin Expression in Primary Human Gut Tissues and Caco-2 Cells

    Zejun Zhou 1, Gary Gilkeson 2, Diane Kamen 3, Jim Oates 4 and Wei Jiang4, 1Medical University of South Carolina, Charleston, SC, 2Division of Rheumatology & Immunology/Ralph H. Johnson VA Medical Center/Medical University of South Carolina, Charleston, SC, 3Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charleston, SC, 4Medical University of South Carolina, Charleston

    Background/Purpose: Progesterone plays a protective role in preventing inflammation and preterm delivery during pregnancy. However, the mechanism involved is unknown. Microbial product translocation from a…
  • Abstract Number: 1934 • 2014 ACR/ARHP Annual Meeting

    Examing Why Minority Women Are Risk Averse : A Qualitative Study

    Sonal Bhalla1, Kristin Mattocks2 and Liana Fraenkel3, 1Yale-New Haven Hospital, New Haven, CT, 2VA Central Western Massachusetts Healthcare System, University of Massachusetts Medical School, Leeds, MA, 3Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare Systems, New Haven, CT

    Background/Purpose: Prior research has shown that when making choices about the risks and benefits of medications, women from minority ethnic groups tend to be more…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology